Liam Taylor

Mercia Fund Management Ltd. (Mercia Fund) is a private equity subsidiary of Mercia Asset Management Plc founded in 1999 by Mark Andrew Payton, Timothy R. Hazell and Everard Mascarenhas. The firm is headquartered in Warwickshire, Great Britain.

Peregrine 66 Ltd. is a British investment services company founded in 2017. The private company is based in London, UK. The company provides investment services.

Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom.

Suntail 66 Ltd. provides financial intermediary services. The private company is based in London, UK.

Calculus Capital Ltd (Calculus Capital) is a private equity and venture capital founded in 1999 by Susan R. McDonald and Arthur J. Glencross. The firm is headquartered in London, United Kingdom.

Essentia Analytics Ltd. develops a platform for professionals to practice skills-based investing technique. The firm also provides consulting services. The company was founded by Clare Pauline Flynn Levy on February 22, 2010 and is headquartered in London, the United Kingdom.

Every1Mobile Africa delivers the mobile and online components of social development programs across Africa and other emerging markets. The firm's customers include international development agencies, commercial companies, NGOs and foundations. The company was founded by Algy Williams and Michael Jenkins and is headquartered in Cape Town, South Africa.

Start Codon Ltd (Start Codon) is a venture capital firm founded in 2018 by Jason Mellad and Marek Tyl. The firm is headquartered in London, United Kingdom.

D.light Design, Inc. designs, manufactures and distributes solar light and power products. It offers solar-powered light emitting diode lanterns and mobile chargers. The firm serves households and small businesses. The company was founded by Samuel Warrack Goldman, Gabriel C. Risk, Nedjip Orhan Tozun, Xianyi Wu, and Erica D. Estrada in 2006 and is headquartered in San Francisco, CA.

Berkshire Capital Securities LLC operates as an independent employee-owned investment bank specializing in Mergers & Acquisitions in the financial services sector. The company has partners located in Philadelphia, Denver, London, Frankfurt and Sydney. Berkshire Capital majorly transacts in the wealth management, money management, alternatives, real estate and broker/dealer industries. The company was founded in 1983 and headquartered in New York.

Turbine Simulated Cell Technologies Ltd. is a British company that leverages AI technology to understand oncology patients with simulated cells. The company is based in London, UK. and has subsidiaries in Hungary. The company was founded in 2019 by Szabolcs Nagy, Ivan Fekete, Daniel Veres, Kristof Zsolt Szalay. Szabolcs Nagy has been the CEO since 2019.

Thanksbox Ltd. develops digital application for creating stronger working relationships and fulfilling workplace needs. The company was founded by Luke Stephen Fisher on August 15, 2013 and is headquartered in London, the United Kingdom.

Part of Sartorius AG, Essen BioScience Ltd. is a British company that sells and markets Essen BioScience products. The company is based in Welwyn Garden City, UK.

Avocet 66 Ltd. is a British financial intermediary company founded in 2017.

Healx Ltd. engages in the development of a platform that enables treatment predictions for rare diseases. It offers HealNet, an artificial intelligence platform for rare diseases. Its solutions include orphan disease strategy, indication expansion, combination therapies, and shelved assets. The company was founded by Tim Guilliams and David Ryall Brownn and is headquartered in Cambridge, the United Kingdom.

Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom.

GeoSpock Ltd. provides data software products. It offers illumin, extrapol and cogn8 products. The company was founded by Steven Marsh and Darrin Mathew Disley in 2013 and is headquartered in Cambridge, the United Kingdom.

PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom.

DefiniGEN Ltd. provides human cell products to the drug discovery sector. Its services include iPSC Differentiation, Gene Editing, CRISPR Modeling and Patient Derived Models. The firm products include Hepatocytes, Intestinal and Pancreatic. The company was founded in April 2012 by Candy Hsin-Hua Cho, Nicolas R. F. Hannan, Roger A. Pedersen and Tamir Rashid and is headquartered in Cambridge, the United Kingdom.

Cambridge Allergy Ltd. operates as a biopharmaceutical company which manufactures medicines for food allergies. The company was founded by Sherden Timmins, Andrew Clark, and Pamela Ewan on December 7, 2015 and is headquartered in Cambridge, the United Kingdom.

Roslin Cell Therapies Ltd. is a leading contract development and manufacturing services organization focused on advanced cell and gene therapies. The company was established in 2006 and is based in Edinburgh, UK. and has subsidiaries in the United States. Roslin Cell Therapies has a remarkable heritage in the field, having been among the first in the world to produce clinical-grade human pluripotent stem cells and advancing the first CRISPR edited stem cell-based therapy for a major disease to marketing authorization. The British company provides innovative process and analytical development, CGMP clinical and commercial manufacturing for a range of cell types, and CGMP iPSC cell line development, gene editing, and differentiation. With tailored CDMO solutions, Roslin Cell Therapies enables partners to efficiently progress from development to commercialization and deliver life-saving cell and gene therapies worldwide. Peter Alistair Coleman has been the CEO of the company since 2022.